Date Modified

2025-07-24

Period

60/months

Report Summary

• Trial commenced on 10.08.2016 • Recruitment status: Recruitment complete • Number assessed for eligibility: 2721 • Number recruited and allocated/ randomized: 2100 • Number of subjects vaccinated with booster dose: 1326 • Date of trial completion: 23.03.2024 • Final sample size: Main phase – 2100, Booster phase - 1326

Attached file